GL1X · GenesisL1 explorer

MolNFT v1 · #129117 · protein

High resolution crystal structure of the C-src-SH3 domain mutant E93V in complex with the high affinity synthetic peptide APP12: monoclinic crystal

5OAV · Proto-oncogene tyrosine-protein kinase src: “High resolution crystal structure of the C-src-SH3 domain mutant E93V in complex with the high affinity…”. X-ray diffraction, 1 ligand (ACE), 1 pocket (best druggability 0.29). MolNFT v1…

PDB
5OAV
Type
protein
Length
132 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src; APP12
EC
2.7.10.2
UniProt
P00523
Ligands
ACE
Pockets
1 · best druggability 0.29

Structure

x-ray diffraction · 3 distinct chains · 4% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein575% helix, 46% strandP00523
BAPP12protein70% helix, 0% strand—
DAPP12protein110% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.290.7417empty

Interfaces

3 interfaces between chains.

  • C–D · 557 Ų buried · 10 hydrogen bonds · protein-protein
  • A–B · 432 Ų buried · 7 hydrogen bonds · protein-protein
  • A–D · 186 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5OAV · High resolution crystal structure of the c-Src-SH3 domain mutant E93V in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.